PL2720563T5 - Metabolic imprinting effects of specifically designed lipid component - Google Patents

Metabolic imprinting effects of specifically designed lipid component

Info

Publication number
PL2720563T5
PL2720563T5 PL12730694.2T PL12730694T PL2720563T5 PL 2720563 T5 PL2720563 T5 PL 2720563T5 PL 12730694 T PL12730694 T PL 12730694T PL 2720563 T5 PL2720563 T5 PL 2720563T5
Authority
PL
Poland
Prior art keywords
specifically designed
lipid component
imprinting effects
metabolic imprinting
designed lipid
Prior art date
Application number
PL12730694.2T
Other languages
Polish (pl)
Other versions
PL2720563T3 (en
Inventor
Eline Marleen Van Der Beek
Marieke Abrahamse-Berkeveld
Annemarie Oosting
Martine Sandra Alles
Original Assignee
N.V. Nutricia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46397603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2720563(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N.V. Nutricia filed Critical N.V. Nutricia
Publication of PL2720563T3 publication Critical patent/PL2720563T3/en
Publication of PL2720563T5 publication Critical patent/PL2720563T5/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L35/00—Foods or foodstuffs not provided for in groups A23L5/00 - A23L33/00; Preparation or treatment thereof
    • A23L35/10—Emulsified foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
PL12730694.2T 2011-06-16 2012-06-18 Metabolic imprinting effects of specifically designed lipid component PL2720563T5 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2011/050437 WO2012173467A1 (en) 2011-06-16 2011-06-16 Metabolic imprinting effects of specifically designed lipid component
PCT/NL2012/050428 WO2012173486A1 (en) 2011-06-16 2012-06-18 Metabolic imprinting effects of specifically designed lipid component

Publications (2)

Publication Number Publication Date
PL2720563T3 PL2720563T3 (en) 2017-02-28
PL2720563T5 true PL2720563T5 (en) 2023-04-24

Family

ID=46397603

Family Applications (4)

Application Number Title Priority Date Filing Date
PL16183396.7T PL3138415T3 (en) 2011-06-16 2012-06-18 Metabolic imprinting effects of specifically designed lipid component
PL12730694.2T PL2720563T5 (en) 2011-06-16 2012-06-18 Metabolic imprinting effects of specifically designed lipid component
PL12730693.4T PL2720562T5 (en) 2011-06-16 2012-06-18 Metabolic imprinting effects of specifically designed lipid component
PL16183392.6T PL3156052T3 (en) 2011-06-16 2012-06-18 Metabolic imprinting effects of specifically designed lipid component

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL16183396.7T PL3138415T3 (en) 2011-06-16 2012-06-18 Metabolic imprinting effects of specifically designed lipid component

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL12730693.4T PL2720562T5 (en) 2011-06-16 2012-06-18 Metabolic imprinting effects of specifically designed lipid component
PL16183392.6T PL3156052T3 (en) 2011-06-16 2012-06-18 Metabolic imprinting effects of specifically designed lipid component

Country Status (14)

Country Link
US (3) US20140170260A1 (en)
EP (4) EP3138415B1 (en)
CN (4) CN106262925A (en)
BR (2) BR112013032008A2 (en)
DK (4) DK2720562T4 (en)
ES (4) ES2601838T5 (en)
HR (4) HRP20161271T1 (en)
MY (2) MY165142A (en)
PH (2) PH12013502465A1 (en)
PL (4) PL3138415T3 (en)
PT (4) PT3138415T (en)
RU (2) RU2586930C2 (en)
SI (4) SI3156052T1 (en)
WO (3) WO2012173467A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
WO2012173467A1 (en) 2011-06-16 2012-12-20 N.V. Nutricia Metabolic imprinting effects of specifically designed lipid component
AR086993A1 (en) 2011-06-20 2014-02-05 Gen Biscuit GALLETITA MASS
SE536599C3 (en) 2012-04-10 2017-01-10 Hero Ag Nutritional composition with low calorie and low protein content
WO2013191533A1 (en) 2012-06-18 2013-12-27 N.V. Nutricia Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat
WO2014058301A1 (en) * 2012-10-12 2014-04-17 N.V. Nutricia Infant nutrition with lipid globules to increase energy expenditure and metabolic flexibility later in life
US9661874B2 (en) 2013-03-11 2017-05-30 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US10455854B2 (en) 2013-03-11 2019-10-29 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US9980506B2 (en) * 2013-03-11 2018-05-29 Mead Johnson Nutrition Co. Nutritional compositions containing structured fat globules and uses thereof
US20140255537A1 (en) * 2013-03-11 2014-09-11 Mead Johnson Nutrition Company Nutritional Compositions Containing an Enriched Lipid Fraction and Uses Thereof
CN105592711A (en) * 2013-07-30 2016-05-18 拜内梅尔克公司 Feed for lactating ruminants
EP2845490A1 (en) * 2013-09-05 2015-03-11 Loders Croklaan B.V. Fat composition for improved body fat distribution
US20160227810A1 (en) * 2013-10-17 2016-08-11 University Of Georgia Research Foundation, Inc. Structured triacylglycerols and methods for making the same
ES2693519T3 (en) * 2013-11-01 2018-12-12 N.V. Nutricia Lipid composition to improve body composition during growth recovery
WO2015067325A1 (en) * 2013-11-11 2015-05-14 N.V. Nutricia Powdered nutritional composition with large lipid globules
US20160015068A1 (en) * 2014-07-16 2016-01-21 Mead Johnson Nutrition Company Nutritional formulas containing oil blends and uses thereof
WO2016086157A1 (en) * 2014-11-26 2016-06-02 Abbott Laboratories Infant formula comprising human milk oligosaccharides, polyunsaturated fatty acids, nucleotides, and lutein
WO2017064304A1 (en) 2015-10-15 2017-04-20 N.V. Nutricia Infant formula with special lipid architecture for promoting healthy growth
CN108366986A (en) * 2015-10-15 2018-08-03 N·V·努特里奇亚 Infant formula with milk fat for promoting healthy growth
US20210392934A1 (en) * 2016-03-10 2021-12-23 Enzymotec Ltd. Lipid compositions and uses thereof
AU2017307952A1 (en) 2016-08-04 2018-11-29 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally Bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
ES2987545T3 (en) 2016-12-09 2024-11-15 Nutricia Nv Nutritional composition for use in improving cognitive performance and/or preventing cognitive decline
CN107049240A (en) * 2017-01-18 2017-08-18 英华达（上海）科技有限公司 Physical age computational methods and bodily fat measurement system
CN110678086B (en) * 2017-03-29 2023-10-20 N·V·努特里奇亚 Infant formulas for improved eating behavior
WO2018178302A1 (en) * 2017-03-29 2018-10-04 N.V. Nutricia Infant formula for improved eating behaviour
CN109418396A (en) * 2017-08-22 2019-03-05 中国农业大学 Artificial fat drips and its application
CN112087956A (en) * 2018-04-03 2020-12-15 N·V·努特里奇亚 Nutritional composition for preventing dry skin
WO2021110916A1 (en) 2019-12-05 2021-06-10 N.V. Nutricia Infant formula with special lipid architecture for improving postnatal growth of infants born to overweight and obese mothers
BR112022010232A2 (en) * 2019-12-05 2022-09-06 Nutricia Nv METHOD FOR NON-THERAPEUTIC IMPROVEMENT OF POST-NATAL GROWTH OR BODY DEVELOPMENT TRAJECTORY IN AN INFANT THAT IS BORN BY CESAREAN AND NUTRITIONAL COMPOSITION
MY208858A (en) * 2020-12-29 2025-06-04 Wilmar Shanghai Biotechnology Res & Dev Ct Co Ltd Composition for improving digestion of lipid contained in food, and use thereof
WO2022248599A1 (en) 2021-05-26 2022-12-01 N.V. Nutricia Infant formula comprising milk fat for reducing the risk of obesity in at risk infants
EP4346447A1 (en) 2021-05-26 2024-04-10 N.V. Nutricia Infant formula for improving body composition development
EP4510845B1 (en) 2022-04-20 2026-05-06 N.V. Nutricia Infant formula with special lipid architecture for reducing childhood blood pressure
WO2024073463A1 (en) * 2022-09-28 2024-04-04 Cargill, Incorporated Oleosome composition
US20260090551A1 (en) * 2022-09-28 2026-04-02 Cargill, Incorporated Oleosome composition
US20260090577A1 (en) * 2022-09-28 2026-04-02 Cargill, Incorporated Oleosome composition with bio-actives
CA3268653A1 (en) * 2022-09-28 2024-04-04 Cargill, Incorporated Sunflower oleosome composition
AU2024217119A1 (en) 2023-02-07 2025-08-07 N.V. Nutricia Nutritional composition with improved segregation resistance
WO2026033137A1 (en) 2024-08-08 2026-02-12 N.V. Nutricia Particulate nutritional composition with large lipid globules
WO2026033138A1 (en) 2024-08-09 2026-02-12 N.V. Nutricia Nutritional composition with large lipid globules and native protein
CN121176888B (en) * 2025-11-24 2026-02-27 四川省医学科学院·四川省人民医院 Fecal hardness assessment method and system for auxiliary defecation system

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601860A (en) 1990-11-30 1997-02-11 American Home Products Corporation Corandomized fat compositions for infant formulas
DE69201651T2 (en) * 1991-01-23 1995-07-13 Unilever Nv Breast milk fat substitutes.
JP2761294B2 (en) 1993-05-13 1998-06-04 ロデルス−クロクラーン Human breast milk fat substitutes derived from transesterified triglyceride blends
IL158554A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Mimetic lipids as dietary supplements
IL158555A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
RU2413430C2 (en) * 2005-04-27 2011-03-10 Энзимотек Лтд. Composition of fat base (versions) and method of its production (versions), composition of breast milk fat substitute and method of its production (version), baby formula
EP1800675B1 (en) * 2005-12-23 2011-05-18 N.V. Nutricia Composition comprising polyunsaturated fatty acids, proteins, manganese and/or molybden and nucleosides/nucleotides for treating dementia
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
ES2537080T3 (en) 2005-12-23 2015-06-02 N.V. Nutricia Composition comprising polyunsaturated fatty acids, proteins and manganese and / or molybdenum to improve the composition of cell membranes
DE102007022694A1 (en) * 2007-05-11 2008-11-13 Humana Milchunion Eg Milk fat milk protein composition to improve calcium absorption
IL184982A0 (en) * 2007-08-01 2008-01-20 Enzymotec Ltd Edible fat composition for enhancing bone strength
FR2930406B1 (en) 2008-04-29 2011-04-15 Groupe Lactalis CHILD-BASED INFANT FEED OF MILK ORIGIN
US8226737B2 (en) 2008-07-03 2012-07-24 3M Innovative Properties Company Fixed abrasive particles and articles made therefrom
EP2143340A1 (en) * 2008-07-07 2010-01-13 Nestec S.A. A nutritional composition with free amino acids and structured lipids
WO2010027259A1 (en) 2008-09-02 2010-03-11 N.V. Nutricia Nutritional compositions with coated lipid globules
WO2010068086A1 (en) * 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
WO2011071367A1 (en) 2009-12-11 2011-06-16 N.V. Nutricia Metabolic imprinting effects of structured lipids
WO2012173467A1 (en) 2011-06-16 2012-12-20 N.V. Nutricia Metabolic imprinting effects of specifically designed lipid component
WO2013191533A1 (en) 2012-06-18 2013-12-27 N.V. Nutricia Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat

Also Published As

Publication number Publication date
DK3138415T3 (en) 2023-01-30
WO2012173467A1 (en) 2012-12-20
HRP20161272T4 (en) 2023-03-31
MY163520A (en) 2017-09-15
DK2720563T4 (en) 2023-04-03
SI2720563T1 (en) 2017-03-31
WO2012173485A1 (en) 2012-12-20
RU2014101160A (en) 2015-07-27
EP3138415B1 (en) 2022-12-14
HRP20161271T1 (en) 2016-12-16
HRP20230159T1 (en) 2023-03-31
ES2601838T3 (en) 2017-02-16
CN103763941A (en) 2014-04-30
US20140170260A1 (en) 2014-06-19
PT2720563T (en) 2016-11-02
PT2720562T (en) 2016-11-02
EP2720563B1 (en) 2016-08-10
PT3156052T (en) 2023-01-27
ES2601302T3 (en) 2017-02-14
ES2939808T3 (en) 2023-04-27
ES2939943T3 (en) 2023-04-28
HRP20161272T1 (en) 2017-02-10
PL2720562T3 (en) 2017-02-28
EP2720563A1 (en) 2014-04-23
PH12013502465A1 (en) 2014-01-20
MY165142A (en) 2018-02-28
ES2601302T5 (en) 2023-06-19
BR112013032008A2 (en) 2016-08-09
RU2014101211A (en) 2015-07-27
CN103687500B (en) 2016-08-31
EP3156052B1 (en) 2022-12-14
EP2720562A1 (en) 2014-04-23
EP2720562B2 (en) 2023-02-22
US20160081963A1 (en) 2016-03-24
RU2586930C2 (en) 2016-06-10
EP2720563B2 (en) 2023-02-22
PT3138415T (en) 2023-01-23
RU2591716C2 (en) 2016-07-20
US20140187480A1 (en) 2014-07-03
DK2720563T3 (en) 2016-10-17
PL3138415T3 (en) 2023-04-03
WO2012173486A1 (en) 2012-12-20
SI3138415T1 (en) 2023-04-28
SI2720563T2 (en) 2023-04-28
US9649286B2 (en) 2017-05-16
PL2720562T5 (en) 2023-04-24
HRP20230160T1 (en) 2023-03-31
DK2720562T4 (en) 2023-04-03
DK2720562T3 (en) 2016-10-24
CN106262925A (en) 2017-01-04
ES2601838T5 (en) 2023-06-19
CN108041605A (en) 2018-05-18
SI3156052T1 (en) 2023-03-31
US9532966B2 (en) 2017-01-03
SI2720562T1 (en) 2017-03-31
EP3138415A1 (en) 2017-03-08
EP2720562B1 (en) 2016-08-10
CN103687500A (en) 2014-03-26
EP3156052A1 (en) 2017-04-19
PH12013502466A1 (en) 2014-01-20
DK3156052T3 (en) 2023-01-30
PL2720563T3 (en) 2017-02-28
PL3156052T3 (en) 2023-05-02
BR112013031916B1 (en) 2020-09-01
BR112013031916A2 (en) 2016-08-09

Similar Documents

Publication Publication Date Title
SI3156052T1 (en) Metabolic imprinting effects of specifically designed lipid component
GB2498228B (en) Provision of an open instance of an application
EP2712362A4 (en) Manufacture of lacto-n-tetraose
ZA201306655B (en) Heterocyclic modulators of lipid synthesis
HUE047354T2 (en) Deuterated derivatives of ivacaftor
PT2709986T (en) Deuterated derivatives of ivacaftor
GB2489934B (en) Film
PT2694116T (en) Lipid-based nanoparticles
EP2724833A4 (en) Surface structure of article
ZA201402990B (en) Choline Composition
GB201216081D0 (en) An item tag-along
EP2684869A4 (en) Preparation of 3-mercaptopropionates
GB201102171D0 (en) Inspection of holes
GB201109913D0 (en) Lipid metabolism
GB201121152D0 (en) Forming of holes in workplieces
GB201109368D0 (en) Eyeliner effect
GB201107200D0 (en) Methods of identifying FOXM1 ligands
GB201109703D0 (en) Magnetic gradiometry
IL216423A0 (en) Moving pictures